By proceeding, you agree to our Terms of Use and Privacy Policy.
Bio-Techne Corporation (NASDAQ: TECH) is a leading developer and manufacturer of high-quality purified proteins and reagent solutions - notably cytokines and growth factors, antibodies, immunoassays, biologically active small molecule compounds, tiss
03-04 November 2021
We're excited to announce that Drug Target Review will be hosting its first ever online summit on Cell & Gene Therapy Advancements and are inviting you to join us for FREE.
Event Ended
Virtual
Paid
16-18 March 2022
IO360°convenes stakeholders from the science and business communities to report on the latest data impacting IO to fight a wider range of cancers.
USA
New York
02-06 May 2022
PEGS Boston Summit highlights a wide spectrum of biologic drug development with in-depth presentations on protein and antibody engineering, immunotherapy, oncology, expression, analytical, immunogenicity, and more.
Hybrid
Boston
15-16 September 2022
Join 250+ leaders, experts and researchers at the Spatial Biology US: In-Person, connecting global academic & research organisations as well as pharma representatives for high-level discussions on the latest innovations in spatial research &
19-22 September 2022
Across 3 main conference days and 8 tracks, 200+ CAR and TCR experts will lead you and your peers in discussions from novel allogeneic approaches with enhanced safety considerations, the latest in vivo gene engineering techniques, and advances in CMC
26-29 September 2022
Marrying Complex Biomarker Validation & CDx Development for Supercharged Precision Oncology Pipeline Commercialization The 12th World Clinical Biomarkers & CDx Summit returns at a crucial time for the entire precision & targeted drug development indu
27-30 September 2022
Each year, CGT's scientific agenda includes 100+ of the industry's top scientists to present the latest updates on how to improve efficiencies across all phases of Cell & Gene Therapy development and production Our agenda for Cell & Gene Therapy Manu
01-02 November 2022
Hear from and meet with the leading figures in biomarker analysis to explore how companies are innovating in biomarker analysis to accelerate timelines and reduce risk in drug development, with in-depth consideration of the latest multiplexed and cyt
Germany
Berlin
14-16 November 2022
Network with more than 1,000 colleagues at PEGS Europe, the largest protein & antibody engineering event in Europe, which has been described as "the best biologics technology meeting in Europe.
Spain
Barcelona
16-17 November 2022
In the wake of new FDA guidance and exciting MRD partnership announcements between Grail & AstraZeneca, Amgen & Bristol Myers Squibb the liquid biopsy industry is experiencing a paradigm shift.
14-16 February 2023
Fast-Tracking Your Test Approvals & Reimbursement Path with Strategic Partnerships to Benefit Patients The 7th Liquid Biopsy for Precision Oncology Summit returns as the largest and most comprehensive forum for all stakeholders in the field to
San Diego
14-15 March 2023
The Advanced Therapies Congress is Europe’s largest cell and gene therapy conference and exhibition. The event is for the leaders of the world’s ATMP developers and their most senior executives in charge of the latest tech and strategies that are dri
UK
London
15-19 May 2023
The world’s largest gathering of protein engineering and biotherapeutics experts is back in Boston! PEGS Boston Summit is the leading biologics event with comprehensive programming covering all aspects of biologic drug development with in-depth prese
16-20 May 2023
The American Society of Gene and Cell Therapy’s (ASGCT) Annual Meeting is the premier event for professionals in gene and cell therapy. The meeting, which we've expanded to four full days in 2023, is the best place for people in the field to learn fr
Los Angeles
14-15 August 2023
Advances in host cell engineering, better expression of cell lines and optimization of cell culture processes, have greatly accelerated upstream processing in the last decade, resulting in today's antibody production yield of 10g/L or more. Meanwhile
Vaccines and mRNA-based vaccines have recently gained a lot of attention due to COVID-19. Cambridge Healthtech Institute’s 3rd Annual Vaccine Development and Manufacturing conference tackles the practical challenges facing the development, manufactur
Cambridge Healthtech Institute’s Gene Therapy CMC and Analytics conference uncovers the practical challenges facing the analysis, characterization, and quality of viral vector-based gene therapies for clinical and commercial supply, with dedicated se
The popular 11th Annual Rapid Methods to Assess Stability and Impurities in Biologics conference will bring together experts in formulation, analytical sciences, and process to discuss rapid and practical ways to accelerate prediction and screening f
Cambridge Healthtech Institute’s Cell Therapy CMC and Analytics conference focuses on the characterization, control, and quality of cell-based therapies, supported by in-depth case studies and insight from leading industry and academic representative
The biopharma industry is driven by the need to increase productivity, reduce cost, while maintaining product quality and consistency. Continuous biomanufacturing and process intensification are borne out of such need. CHI’s Intensified & Continuous
Characterizing and controlling process-related impurities, such as host cell proteins (HCPs), is a critical part of bioprocessing, with regulators now pressing companies for more data and questions emerging on the role of HCPs in emerging modalities.
14-17 August 2023
The Bioprocessing Summit 2023, now in its fifteenth year, stands as the premier global forum for industry leaders to converge and exchange groundbreaking advancements in bioprocess research and development, scale-up, quality, and analytics. This high
16-17 August 2023
The approval of COVID-19 vaccines was the breakthrough for mRNA-based technology, and it opened so many opportunities for mRNA-based vaccines and therapeutics. CHI’s 2nd Annual mRNA-Based Therapies conference will explore the technical challenges fac
Pharmaceutical companies today are increasingly harnessing the power of digitalization to drive scientific and operational excellence across the value chain, from R&D to manufacturing. Digitalization is a key enabler to smarter bioprocessing and to h
Industry analytical groups are facing increased pressure to deliver key studies faster than ever before – and at lower costs. Cambridge Healthtech Institute’s 10th Annual Accelerating Analytical Development conference offers a best practices forum in
Newer and more complex molecules coming down the pipeline are bringing a new set of challenges to the downstream process development team, leading to the search for innovative technologies to meet the demand for higher yield while maintaining product
The development of high-concentration protein formulations for traditional and novel biologic products can be challenging during manufacturing, storage, and delivery due to problems such as aggregation, precipitation, gelation, and high viscosity. Th
Cambridge Healthtech Institute’s Gene Therapy Manufacturing conference discusses the practical challenges facing the production, purification, and manufacturing of viral and non-vector-based gene therapies. Topics include: AAV and lentivirus upstream
CHI’s Cell Therapy Manufacturing conference examines the practical challenges in manufacturing autologous and allogenic cell therapies at scale, with dedicated sessions on cell processing, scalability, next-generation production technologies, automat
29-31 August 2023
Join us for the inaugural Gene Therapy Potency Assay Summit on August 29-31, where we will equip you with the necessary tools to identify, characterize, and measure potency in your gene therapy development. Our summit is dedicated to addressing the c
05-08 September 2023
Welcome to the 13th Annual World Clinical Biomarkers & CDx Summit, the highly anticipated gathering that brings together over 600 senior decision makers in the field of biomarkers and companion diagnostics (CDx). This industry-led meeting aims to acc
30-02 November 2023
The 6th Targeted Protein Degradation Summit is the premier event for professionals in the field of protein degradation drug development. Returning to Boston in 2023, this summit has established itself as the longest-standing and most comprehensive ga